S&P 500   3,839.77 (-0.04%)
DOW   30,795.18 (-0.65%)
QQQ   328.89 (+1.07%)
AAPL   144.06 (+3.59%)
MSFT   228.29 (+1.04%)
FB   275.85 (+0.49%)
GOOGL   1,884.10 (-0.45%)
AMZN   3,306.20 (+0.42%)
TSLA   879.82 (+3.92%)
NVDA   542.54 (-1.09%)
BABA   262.12 (+1.35%)
CGC   33.87 (+0.21%)
GE   11.05 (-0.54%)
MU   81.20 (-1.31%)
AMD   94.49 (+1.83%)
NIO   63.08 (+1.82%)
T   28.93 (+0.00%)
F   11.19 (-2.86%)
ACB   10.55 (-0.94%)
BA   202.68 (-1.54%)
DIS   171.20 (-0.91%)
NFLX   557.95 (-1.28%)
GILD   67.30 (+0.54%)
S&P 500   3,839.77 (-0.04%)
DOW   30,795.18 (-0.65%)
QQQ   328.89 (+1.07%)
AAPL   144.06 (+3.59%)
MSFT   228.29 (+1.04%)
FB   275.85 (+0.49%)
GOOGL   1,884.10 (-0.45%)
AMZN   3,306.20 (+0.42%)
TSLA   879.82 (+3.92%)
NVDA   542.54 (-1.09%)
BABA   262.12 (+1.35%)
CGC   33.87 (+0.21%)
GE   11.05 (-0.54%)
MU   81.20 (-1.31%)
AMD   94.49 (+1.83%)
NIO   63.08 (+1.82%)
T   28.93 (+0.00%)
F   11.19 (-2.86%)
ACB   10.55 (-0.94%)
BA   202.68 (-1.54%)
DIS   171.20 (-0.91%)
NFLX   557.95 (-1.28%)
GILD   67.30 (+0.54%)
S&P 500   3,839.77 (-0.04%)
DOW   30,795.18 (-0.65%)
QQQ   328.89 (+1.07%)
AAPL   144.06 (+3.59%)
MSFT   228.29 (+1.04%)
FB   275.85 (+0.49%)
GOOGL   1,884.10 (-0.45%)
AMZN   3,306.20 (+0.42%)
TSLA   879.82 (+3.92%)
NVDA   542.54 (-1.09%)
BABA   262.12 (+1.35%)
CGC   33.87 (+0.21%)
GE   11.05 (-0.54%)
MU   81.20 (-1.31%)
AMD   94.49 (+1.83%)
NIO   63.08 (+1.82%)
T   28.93 (+0.00%)
F   11.19 (-2.86%)
ACB   10.55 (-0.94%)
BA   202.68 (-1.54%)
DIS   171.20 (-0.91%)
NFLX   557.95 (-1.28%)
GILD   67.30 (+0.54%)
S&P 500   3,839.77 (-0.04%)
DOW   30,795.18 (-0.65%)
QQQ   328.89 (+1.07%)
AAPL   144.06 (+3.59%)
MSFT   228.29 (+1.04%)
FB   275.85 (+0.49%)
GOOGL   1,884.10 (-0.45%)
AMZN   3,306.20 (+0.42%)
TSLA   879.82 (+3.92%)
NVDA   542.54 (-1.09%)
BABA   262.12 (+1.35%)
CGC   33.87 (+0.21%)
GE   11.05 (-0.54%)
MU   81.20 (-1.31%)
AMD   94.49 (+1.83%)
NIO   63.08 (+1.82%)
T   28.93 (+0.00%)
F   11.19 (-2.86%)
ACB   10.55 (-0.94%)
BA   202.68 (-1.54%)
DIS   171.20 (-0.91%)
NFLX   557.95 (-1.28%)
GILD   67.30 (+0.54%)
Log in
NYSE:BIO

Bio-Rad Laboratories Earnings Date, Estimates & History

$591.76
-3.07 (-0.52 %)
(As of 01/25/2021 10:51 AM ET)
Add
Compare
Today's Range
$589.25
Now: $591.76
$599.36
50-Day Range
$541.87
MA: $587.05
$629.12
52-Week Range
$309.38
Now: $591.76
$648.39
Volume600 shs
Average Volume250,043 shs
Market Capitalization$17.65 billion
P/E Ratio5.07
Dividend YieldN/A
Beta0.83

Earnings

Bio-Rad Laboratories (NYSE:BIO) Earnings Information

Bio-Rad Laboratories last announced its earnings results on October 29th, 2020. The medical research company reported $3.00 EPS for the quarter, beating the consensus estimate of $1.85 by $1.15. The business had revenue of $647.26 million for the quarter, compared to analyst estimates of $567.35 million. Its revenue for the quarter was up 15.5% on a year-over-year basis. Bio-Rad Laboratories has generated $7.06 earnings per share over the last year and currently has a price-to-earnings ratio of 5.1. Bio-Rad Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 11th, 2021 based off prior year's report dates.

Bio-Rad Laboratories Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Bio-Rad Laboratories (NYSE:BIO) Earnings Estimates

2021 EPS Consensus Estimate: $9.50
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20211$2.25$2.25$2.25
Q2 20211$2.56$2.56$2.56
Q3 20211$2.18$2.18$2.18
Q4 20211$2.51$2.51$2.51

Bio-Rad Laboratories (NYSE BIO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/11/2021
(Estimated)
       
10/29/20209/30/2020$1.85$3.00($37.64)$567.35 million$647.26 millionTranscript
7/30/2020Q2 2020$1.22$1.61($28.93)$526.80 million$536.88 millionListen
5/6/20203/31/2020$1.57$1.91($18.90)$545.70 million$571.60 millionTranscript
2/13/2020Q4 2019$2.44$2.32($13.67)$636.50 million$624.43 millionTranscript
10/31/2019Q3$1.36$1.61$11.90$561.40 million$560.60 millionTranscript
8/1/2019Q2 2019$1.39$1.57($16.72)$564.88 million$572.60 millionListen
5/8/20193/31/2019$1.12$1.65($25.44)$548.82 million$553.98 millionListen
2/28/2019Q4 2018$1.61$2.13$32.14$610.65 million$617.54 millionN/A
11/1/20189/30/2018$1.16$0.91($7.07)$541.23 million$545.10 millionTranscript
8/7/2018Q2 2018$1.27$1.64($5.59)$551.05 million$575.91 millionN/A
5/8/2018Q1 2018$1.07$1.17($19.43)$527.20 million$551.52 millionN/A
2/27/2018Q4 2017$1.28$1.50$0.68$618.89 million$620.43 millionN/A
11/2/2017Q3 2017$0.54$0.91$0.91$507.99 million$535.00 millionN/A
8/3/2017Q2 2017$0.63$0.58$0.99$515.04 million$504.67 millionN/A
5/4/2017Q1 2017$0.27$0.41$0.41$477.76 million$500.05 millionListen
2/23/2017Q416$1.03($0.70)$3.20$574.40 million$571.45 millionN/A
11/1/2016Q316$0.51$0.62$0.62$480.60 million$508.75 millionN/A
8/3/2016Q2$1.13$0.61$0.61$497.80 million$516.80 millionN/A
5/5/2016Q1$0.60$0.42$0.42$463.90 million$471.20 millionN/A
2/25/2016Q415$1.27$1.68$1.68$570.80 million$570.56 millionListen
11/3/2015Q315$0.54$0.59$0.59$495.55 million$469.96 millionN/A
8/6/2015Q215$0.78$0.97$0.97$494.85 million$506.10 millionN/A
5/5/2015Q115$0.33$0.61$0.61$474.60 million$472.80 millionN/A
2/26/2015Q414$1.18$1.34$1.34$593.41 million$598.20 millionN/A
11/4/2014Q314$0.86$0.39$0.39$525.40 million$530.64 millionN/A
8/5/2014Q214$0.95$1.09$1.09$537.58 million$536.80 millionTranscript
5/6/2014Q114$0.80$0.23$0.23$515.00 million$509.30 millionN/A
2/27/2014Q413$1.42$1.04$586.67 million$602.60 millionListen
11/8/2013Q3 2013$0.66$0.56$1.37$529.02 million$505.10 millionListen
8/6/2013Q2 2013$1.12$1.20$1.20$532.60 million$525.30 millionListen
5/7/2013Q1 2013$1.10$0.68$0.68$506.34 million$499.70 millionN/A
2/26/2013Q4 2012$1.33$1.65$558.68 million$573.80 millionTranscript
11/6/2012Q312$1.14$1.48$507.79 million$498.70 millionN/A
8/7/2012$1.19$1.69N/A
5/1/2012$1.02$1.09Transcript
2/23/2012$1.67$2.08N/A
11/1/2011$1.53$1.61N/A
8/2/2011$1.47$1.41N/A
5/3/2011$1.32$1.16N/A
2/24/2011$1.35$2.41N/A
11/2/2010Q3 2010$1.17$1.59$1.59N/A
8/3/2010Q2 2010$1.27$1.35$1.35N/A
5/4/2010Q1 2010$1.17$1.24$1.24N/A
2/24/2010Q4 2009$1.08$1.49$1.63N/A
11/3/2009Q3 2009$1.00$1.38$1.38N/A
8/4/2009Q2 2009$1.03$1.37$1.37N/A
5/5/2009Q1 2009$0.98$1.10$1.10N/A
2/26/2009Q4 2008$0.90$1.18$2.66N/A
11/6/2008Q3 2008$1.06$1.01$1.01N/A
8/5/2008Q2 2008$1.08$1.58$1.58N/A
5/6/2008Q1 2008$0.99$0.97$0.97N/A
2/28/2008Q4 2007$0.80$0.92$1.39N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.